Heme oxygenase expression in diabetes and in renal diseases: Mechanisms of cytoprotection

Drug Discovery Today: Disease Mechanisms

Volumn 4, Issue 1, 2007, Pages 41-46

  Abraham, Nader G ^a   Tsenovoy, Peter L ^a   Goodman, Alvin I ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; BILIRUBIN; CARBON MONOXIDE; CREATININE; CYCLOSPORIN; GROWTH FACTOR; HEME; HEME OXYGENASE; HEME OXYGENASE 1; HEME OXYGENASE 2; REACTIVE OXYGEN METABOLITE; RIFAMPICIN; SUPEROXIDE;

BLOOD PRESSURE; BLOOD VESSEL INJURY; CELL PROTECTION; CREATININE BLOOD LEVEL; DIABETES MELLITUS; ENZYME DEFICIENCY; HENLE LOOP; HUMAN; KIDNEY DISEASE; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; KIDNEY INJURY; KIDNEY STRUCTURE; KIDNEY TUBULE DAMAGE; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; REVIEW;

EID: 47049121995     PISSN: 17406765     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ddmec.2007.06.006     Document Type: Review

References (77)

1. Abraham N.G., et al. Heme metabolism in hepatic and erythroid cells. In: Brown E. (Ed). Progress in Hematology (1983), Grune and Stratton 75-130
2. Abraham N.G., et al. The biological significance and physiological role of heme oxygenase. Cell. Physiol. Biochem. 6 (1996) 129-168
3. Cruse I., et al. Evidence suggesting that the two forms of heme oxygenase are products of different genes. J. Biol. Chem. 263 (1988) 3348-3353
4. Vile G.F., et al. Heme oxygenase 1 mediates an adaptive response to oxidative stress in human skin fibroblasts. Proc. Natl. Acad. Sci. U S A 91 (1994) 2607-2610
5. Wagener F.A., et al. Differential effects of heme oxygenase isoforms on heme mediation of endothelial intracellular adhesion molecule 1 expression. J. Pharmacol. Exp. Ther. 291 (1999) 416-423
6. Abraham N.G., et al. Transfection of the human heme oxygenase gene into rabbit coronary microvessel endothelial cells: protective effect against heme and hemoglobin toxicity. Proc. Natl. Acad. Sci. U S A 92 (1995) 6798-6802
7. Balla G., et al. Ferritin: a cytoprotective antioxidant strategy of endothelium. J. Biol. Chem. 267 (1992) 18148-18153
8. Hayashi S., et al. Induction of heme oxygenase-1 suppresses venular leukocyte adhesion elicited by oxidative stress: role of bilirubin generated by the enzyme. Circ. Res. 85 (1999) 663-671
9. Nath K.A., et al. The indispensability of heme oxygenase-1 in protecting against acute heme protein-induced toxicity in vivo. Am. J. Pathol. 156 (2000) 1527-1535
10. Stocker R., et al. Bilirubin is an antioxidant of possible physiological importance. Science 235 (1987) 1043-1046
11. Abraham N.G., et al. Heme oxygenase and the cardiovascular-renal system. Free Radic. Biol. Med. 39 (2005) 1-25
12. Ryter S.W., et al. Heme oxygenase-1/carbon monoxide: from basic science to therapeutic applications. Physiol. Rev. 86 (2006) 583-650
13. Kushida T., et al. TNF-alpha-mediated cell death is attenuated by retrovirus delivery of human heme oxygenase-1 gene into human microvessel endothelial cells. Transplant. Proc. 34 (2002) 2973-2978
14. Kushida T., et al. Role of human heme oxygenase-1 in attenuating TNF-alpha-mediated inflammation injury in endothelial cells. J. Cell Biochem. 87 (2002) 377-385
15. Stocker R., et al. Antioxidant activity of albumin-bound bilirubin. Proc. Natl. Acad. Sci. U S A 84 (1987) 5918-5922
16. Ossola J.O., et al. Heme oxygenase induction by cadmium chloride: evidence for oxidative stress involvement. Toxicology 104 (1995) 141-147
17. Ossola J.O., et al. Heme oxygenase induction by UVA radiation. A response to oxidative stress in rat liver. Int. J. Biochem. Cell Biol. 30 (1998) 285-292
18. Clark J.E., et al. Heme oxygenase-1-derived bilirubin ameliorates postischemic myocardial dysfunction. Am. J. Physiol. Heart Circ. Physiol. 278 (2000) H643-H651
19. Mazza F., et al. Heme oxygenase I gene expression attenuates angiotensin II-mediated DNA damage in endothelial cells. Exp. Biol. Med. 228 (2003) 576-583
20. Sedlak T.W., et al. Bilirubin benefits: cellular protection by a biliverdin reductase antioxidant cycle. Pediatrics 113 (2004) 1776-1782
21. Turkseven S., et al. Antioxidant mechanism of heme oxygenase-1 involves an increase in superoxide dismutase and catalase in experimental diabetes. Am. J. Physiol. Heart Circ. Physiol. 289 (2005) H701-H707
22. Abraham N.G., et al. Overexpression of human heme oxygenase-1 attenuates endothelial cell sloughing in experimental diabetes. Am. J. Physiol. Heart Circ. Physiol. 287 (2004) H2468-H2477
23. Sacerdoti D., et al. Treatment with tin prevents the development of hypertension in spontaneously hypertensive rats. Science 243 (1989) 388-390
24. Levere R.D., et al. Effect of heme arginate administration on blood pressure in spontaneously hypertensive rats. J. Clin. Invest. 86 (1990) 213-219
25. Motterlini R., et al. NO-mediated activation of heme oxgenase: endogenous cytoprotection against oxidative stress to endothelium. Am. J. Physiol. 270 (1996) H107-H114
26. Stanford S.J., et al. Heme oxygenase is expressed in human pulmonary artery smooth muscle where carbon monoxide has an anti-proliferative role. Eur. J. Pharmacol. 473 (2003) 135-141
27. Ndisang J.F., et al. Carbon monoxide and hypertension. J. Hypertens. 22 (2004) 1057-1074
28. Ushiyama M., et al. Carbon monoxide regulates blood pressure cooperatively with nitric oxide in hypertensive rats. Heart Vessels 16 (2002) 189-195
29. Rodella L., et al. Carbon monoxide and biliverdin prevent endothelial cell sloughing in rats with type I diabetes. Free Radic. Biol. Med. 40 (2006) 2198-2205
30. Wang R., et al. Carbon monoxide-induced vasorelaxation and the underlying mechanisms. Br. J. Pharmacol. 121 (1997) 927-934
31. Kaide J.-I., et al. Carbon monoxide of vascular origin attenuates the sensitivity of renal arterial vessels to vasoconstrictors. J. Clin. Invest. 107 (2001) 1163-1171
32. Morita T., et al. Smooth muscle cell-derived carbon monoxide is a regulator of vascular cGMP. Proc. Natl. Acad. Sci. U S A 92 (1995) 1475-1479
33. Ndisang J.F., et al. Alterations in heme oxygenase/carbon monoxide system in pulmonary arteries in hypertension. Exp. Biol. Med. (Maywood.) 228 (2003) 557-563
34. Ahmad M., et al. Heme oxygenase-1 gene expression increases vascular relaxation and decreases inducible nitric oxide synthase in diabetic rats. Cell. Mol. Biol. 51 (2005) 371-376
35. Abraham N.G., et al. Heme oxygenase-1 attenuates glucose-mediated cell growth arrest and apoptosis in human microvessel endothelial cells. Circ. Res. 93 (2003) 507-514
36. Quan S., et al. Heme oxygenase-1 prevents superoxide anion associated endothelial cell sloughing in diabetic rats. Biochem. Biophys. Res. Commun. 315 (2004) 509-516
37. Sacerdoti D., et al. Heme oxygenase overexpression attenuates glucose-mediated oxidative stress in quiescent cell phase: linking heme to hyperglycemia complications. Curr. Neurovasc. Res. 2 (2005) 103-111
38. Chang S.H., et al. Glucose deprivation induces heme oxygenase-1 gene expression by a pathway independent of the unfolded protein response. J. Biol. Chem. 277 (2002) 1933-1940
39. Chang S.H., et al. Haem oxygenase 1 gene induction by glucose deprivation is mediated by reactive oxygen species via the mitochondrial electron-transport chain. Biochem. J. 371 (2003) 877-885
40. Appleton S.D., et al. Effect of glucose and oxygen deprivation on heme oxygenase expression in human chorionic villi explants and immortalized trophoblast cells. Am. J. Physiol. Regul. Integr. Comp. Physiol. 285 (2003) R1453-R1460
41. Liu X., et al. Absence of heme oxygenase-1 exacerbates myocardial ischemia/reperfusion injury in diabetic mice. Diabetes 54 (2005) 778-784
42. Di Filippo C., et al. Hyperglycemia in streptozotocin-induced diabetic rat increases infarct size associated with low levels of myocardial HO-1 during ischemia/reperfusion. Diabetes 54 (2005) 803-810
43. Takeda K., et al. Transient glucose deprivation causes upregulation of heme oxygenase-1 and cyclooxygenase-2 expression in cardiac fibroblasts. J. Mol. Cell Cardiol. 36 (2004) 821-830
44. Colombrita C., et al. Heme oxygenase-1 expression levels are cell cycle dependent. Biochem. Biophys. Res. Commun. 308 (2003) 1001-1008
45. Yang L., et al. Retrovirus-mediated HO gene transfer into endothelial cells protects against oxidant-induced injury. Am. J. Physiol. 277 (1999) L127-L133
46. Abraham N.G., et al. Retinal pigment epithelial cell-based gene therapy against hemoglobin toxicity. Int. J. Mol. Med. 1 (1998) 657-663
47. Choi B.M., et al. Critical role of heme oxygenase-1 in Foxp3-mediated immune suppression. Biochem. Biophys. Res. Commun. 327 (2005) 1066-1071
48. Pae H.O., et al. Carbon monoxide produced by heme oxygenase-1 suppresses T cell proliferation via inhibition of IL-2 production. J. Immunol. 172 (2004) 4744-4751
49. Chen S., et al. Interleukin 10 attenuates neointimal proliferation and inflammation in aortic allografts by a heme oxygenase-dependent pathway. Proc. Natl. Acad. Sci. U S A 102 (2005) 7251-7256
50. Chauveau C., et al. Heme oxygenase-1 expression inhibits dendritic cell maturation and proinflammatory function but conserves IL-10 expression. Blood 106 (2005) 1694-1702
51. Li M., et al. Long-lasting expression of HO-1 delays progression of Type I diabetes in NOD mice. Cell Cycle 6 (2007) 3-7
52. Hu C.M., et al. Systemic expression of heme oxygenase-1 ameliorates type 1 diabetes in nod mice. Diabetes 56 (2007) 1240-1247
53. Koya D., et al. Effects of antioxidants in diabetes-induced oxidative stress in the glomeruli of diabetic rats. J. Am. Soc. Nephrol. 14 (2003) S250-S253
54. Brezniceanu M.L., et al. Catalase overexpression attenuates angiotensinogen expression and apoptosis in diabetic mice. Kidney Int. (2007) [Epub ahead of print]
55. Tanaka Y., et al. Hepatic ischemia-reperfusion induces renal heme oxygenase-1 via NF-E2-related factor 2 in rats and mice. Mol. Pharmacol. 71 (2007) 817-825
56. Harrison E.M., et al. Insulin induces heme oxygenase-1 through the phosphatidylinositol 3-kinase/Akt pathway and the Nrf2 transcription factor in renal cells. FEBS J. 273 (2006) 2345-2356
57. Goodman A.I., et al. Heme oxygenase-2 deficiency contributes to diabetes-mediated increase in superoxide anion and renal dysfunction. J. Am. Soc. Nephrol. 17 (2006) 1073-1081
58. Botros, F.T. et al. (2001) Regulation of cyclooxygenase- and cytochrome P450-derived eicosanoids by heme oxygenase isoforms in rat kidney. Hypertension 38, 505-506 (Ref. Type: Abstract)
59. Kiemer A.K., et al. Characterization of heme oxygenase 1 (heat shock protein 32) induction by atrial natriuretic peptide in human endothelial cells. Endocrinology 144 (2003) 802-812
60. Rezzani R., et al. Change in renal heme oxygenase expression in cyclosporine A-induced injury. J. Histochem. Cytochem. 53 (2005) 105-112
61. Visner G.A., et al. Rapamycin induces heme oxygenase-1 in human pulmonary vascular cells: implications in the antiproliferative response to rapamycin. Circulation 107 (2003) 911-916
62. Nath K.A. Heme oxygenase-1: a provenance for cytoprotective pathways in the kidney and other tissues. Kidney Int. 70 (2006) 432-443
63. Arregui B., et al. Acute renal hemodynamic effects of dimanganese decacarbonyl and cobalt protoporphyrin. Kidney Int. 65 (2004) 564-574
64. Rodriguez F., et al. Effects of exogenous heme on renal function. Role of heme oxygenase and cyclooxygenase. Hypertension 42 (2003) 680-684
65. Nath K.A. Renal response to repeated exposure to endotoxin: implications for acute kidney injury. Kidney Int. 71 (2007) 477-479
66. Pradhan A., et al. Heme-oxygenase upregulation ameliorates angiotensin II-induced tubulointerstitial injury and salt-sensitive hypertension. Am. J. Nephrol. 26 (2006) 552-561
67. Tomita M., et al. Paraquat-induced gene expression in rat kidney. Arch. Toxicol. 80 (2006) 687-693
68. Haugen E.N., et al. Angiotensin II induces renal oxidant stress in vivo and heme oxygenase- 1 in vivo and in vitro. Kidney Int. 58 (2000) 144-152
69. Yang L., et al. Heme oxygenase-1 gene expression modulates angiotensin II-induced increase in blood pressure. Hypertension 43 (2004) 1221-1226
70. Quan S., et al. Expression of human heme oxygenase-1 in the thick ascending limb attenuates angiotensin II-mediated increase in oxidative injury. Kidney Int. 65 (2004) 1628-1639
71. Chung S.W., and Perrella M.A. Role of H-1 in renoprotection: location, location, location. Kidney Int. 65 (2004) 1968-1969
72. Martasek P., et al. Hemin and L-arginine regulation of blood pressure in spontaneous hypertensive rats. J. Am. Soc. Nephrol. 2 (1991) 1078-1084
73. Botros F.T., et al. Increase in heme oxygenase-1 levels ameliorates renovascular hypertension. Kidney Int. 68 (2005) 2745-2755
74. Kim J.H., et al. Heme oxygenase-1 protects rat kidney from ureteral obstruction via an antiapoptotic pathway. J. Am. Soc. Nephrol. 17 (2006) 1373-1381
75. Olszanecki R., et al. Genetic suppression of HO-1 exacerbates renal damage: reversed by an increase in the anti-apoptotic signaling pathway. Am. J. Physiol. Renal. Physiol. 292 (2007) F148-F157
76. Goodman, A.I. et al. (2007) Mechanism of heme oxygenase-1-mediated protection against acute kidney injury: a decrease in caspase and the activation of anti-apoptotic signaling proteins. Kidney Int. (in press)
77. Abraham, N.G. et al. (2007) Pharmacological and Physiological Role of Heme Oxygenase In Normal and Pathological Circumstances. Pharmacol. Rev. (submitted)